Welcome to our dedicated page for Cyanotech SEC filings (Ticker: CYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cyanotech Corporation (CYAN) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, referenced throughout its financial news releases. Cyanotech is a microalgae-based dietary ingredient and supplement manufacturer that files annual reports on Form 10‑K and quarterly reports on Form 10‑Q with the U.S. Securities and Exchange Commission.
In these filings, Cyanotech presents detailed financial statements, including net sales, cost of sales, gross profit, operating expenses, operating income or loss, interest expense, and net income or loss. The company’s recent press releases explicitly direct investors to specific Forms 10‑K and 10‑Q for more comprehensive information on periods such as fiscal years ended March 31 and quarters ended June 30, September 30 and December 31.
Because Cyanotech operates in the medicinal and botanical manufacturing sector with a focus on microalgae, its SEC reports are particularly relevant for understanding the performance of bulk and packaged product sales, contract extraction activity, inventory levels, debt and credit facilities, and the economics of its 96‑acre Kona, Hawaii production facility. The filings also complement the company’s discussion of tariffs, macroeconomic conditions and other factors mentioned in earnings releases.
On Stock Titan, investors can view Cyanotech’s historical and current SEC filings alongside AI-powered summaries that highlight key points from lengthy documents such as Form 10‑K and Form 10‑Q. Real-time updates from the EDGAR system help users see new filings as they become available, while structured access to ownership and transaction data from forms like Form 4, when filed, can provide additional context on insider activity at Cyanotech.
Cyanotech Corporation (CYAN) filed its quarterly report for the period ended September 30, 2025. Net sales rose to $6.976 million from $5.845 million, driven by stronger packaged and bulk astaxanthin and spirulina demand. Gross profit improved to $2.393 million with margin at 34.3% versus 25.3% a year ago as higher production volumes lowered unit costs and select price increases aided mix.
Operating expenses fell to $2.203 million, producing operating income of $190,000 (prior year loss of $975,000). After interest expense of $189,000, net income was $1,000, or $0.00 per share. For the six months, net sales were $12.797 million and net loss was $925,000.
Liquidity remains tight: cash was $649,000 and working capital $39,000. Debt included $370,000 on the 2023 bank term loan (maturing March 31, 2026), $2.809 million on the 2012 loan (amortizing to August 2032), and a related-party revolver with $4.200 million outstanding (capacity $4.600 million, expiring April 12, 2027). The company notes substantial doubt about continuing as a going concern, citing prior covenant noncompliance (waived) and a bank freeze on further line advances. As of
Jennifer A.S. Miyashiro, an officer of Cyanotech Corp (CYAN), was granted 50,000 stock options on 09/12/2025. The options carry an exercise price of $0.29 and expire on 09/12/2035. Following the grant, Ms. Miyashiro beneficially owns 50,000 underlying shares directly. The options vest in three tranches: 16,666 shares on 09/12/2026, 16,667 shares on 09/12/2027 and 16,667 shares on 09/12/2028, each subject to continued service with Cyanotech on the vesting date. The Form 4 was signed by Linda Tanoai by power of attorney on 09/15/2025.
Cyanotech Corp (CYAN) disclosure: Jennifer A.S. Miyashiro is reported as an officer (Chief Financial Officer, Vice President Finance & Administration, Treasurer) of the company and the filing is an initial Form 3 disclosing beneficial ownership. The filing states that the reporting person does not beneficially own any securities of the issuer as reported in this initial statement.
FAQ
What is the current stock price of Cyanotech (CYAN)?
What is the market cap of Cyanotech (CYAN)?
